Friess Associates’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
Friess Associates's ACLS Position: Q2 2022 in Review
Friess Associates sold out of Axcelis (ACLS) in Q2 2022, closing a stake of 34,436 shares — an estimated $2.6M sold.
Friess Associates first reported a position in ACLS in Q1 2017 and held it in 8 quarters. The position peaked at $4.15M in Q1 2020. 276 funds tracked by Wall St. Rank hold ACLS as of Q2 2022.
- Friess Associates reported no remaining Axcelis position as of Q2 2022 after selling out during the quarter.
- Friess Associates sold 34,436 Axcelis shares in Q2 2022, an estimated $2.6M.
- Friess Associates first reported a position in Axcelis in Q1 2017 and held it in 8 quarters.
- Friess Associates's Axcelis position peaked at $4.15M in Q1 2020.
- 276 funds tracked by Wall St. Rank held Axcelis as of Q2 2022.
Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.